Sfrp4 as a Novel Diagnostic and Therapeutic Target for Gastric Cancer

Grant number: 1039393 | Funding period: 2012 - 2015

Completed

Abstract

Gastric cancer is a common cancer with poor survival, but is and potentially curable when diagnosed at an early stage. However currently there are no non-invasive markers for the early detection of gastric cancer, and treatments for advanced cancer are limited. Secreted frizzled related protein 4 (SFRP4) is a protein that is thought to play a role in invasion of gastric cancer. This study will investigate the utility SFRP4 as a diagnostic test and possible therapeutic for gastric cancer.

Related publications (2)

Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer

S Pattison, C Mitchell, S Lade, T Leong, RA Busuttil, A Boussioutas

2017-09-01

Background: Survival from gastric cancer remains poor, particularly in Western populations. Previous pre-clinical and subgroup ana..

Predictors of outcome after surgery for gastric cancer in a Western cohort

S Pattison, GB Mann, G Crosthwaite, S Lade, C Mitchell, T Leong, RA Busuttil, A Boussioutas

2016-06-01

Background: Gastric cancer (GC) is a common cause of cancer mortality. There are well-documented prognostic factors for GC but the..

University of Melbourne Researchers

Alex Boussioutas